APPLICATION
ANDA077927
TYPE
ANDA
ORIGINAL APPROVAL
2006-12-20
LATEST ACTION
2024-11-21
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription
Products
MELOXICAMPrescription
MELOXICAM 15MG · TABLET · ORAL
MELOXICAMPrescription
MELOXICAM 7.5MG · TABLET · ORAL
Approval history
2024-11-21Labeling · Supplement 48 · standardAP
2024-05-10Labeling · Supplement 44 · standardAP
2019-10-22Labeling · Supplement 26 · standardAP
2015-03-02Labeling · Supplement 17 · standardAP
2013-06-13Labeling · Supplement 14 · standardAP
2011-03-31Labeling · Supplement 11AP
2011-03-03Labeling · Supplement 9AP
2009-01-21Labeling · Supplement 2AP
2006-12-20OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.